SCHEMBL3685281

SCHEMBL3685281

CCOC(=O)c1sc2ccc(Cl)cc2c1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.45
KDM4E B2RXH2 7/20 0.45
LMNA P02545 4/20 0.44
TP53 P04637 2/20 0.44
ALDH1A1 P00352 8/20 0.43
TRPM8 Q7Z2W7 2/20 0.43
MAPK1 P28482 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAOB P27338 1/20 0.43
KMT2A Q03164 6/20 0.42
MEN1 O00255 4/20 0.42
HTT P42858 2/20 0.42
MCL1 Q07820 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HPGD P15428 2/20 0.41
TSHR P16473 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ALOX15 P16050 1/20 0.41
CASP1 P29466 1/20 0.41
HSP90AA1 P07900 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL160072 0.86 CMA1 (0.44) MAPTKDM4ELMNAALDH1A1MAPK1
SCHEMBL6659125 0.83 MAPT (0.49) MAPTKDM4ELMNAALDH1A1TRPM8
SCHEMBL15147237 0.81 BCKDK (0.41) MAPTKDM4EALDH1A1MAOBKMT2A
SCHEMBL19024706 0.81 KDM4E (0.57) MAPTKDM4ELMNAALDH1A1TRPM8
SCHEMBL148094 0.80 MCL1 (0.53) MAPTKDM4EMAPK1MAOBMCL1
SCHEMBL144003 0.80 MCL1 (0.42) MAPTKDM4EMAOBMCL1NPC1
SCHEMBL6660225 0.79 MAPT (0.46) MAPTKDM4ELMNATP53ALDH1A1
SCHEMBL8331825 0.76 PFKFB3 (0.44) MAPTKDM4ELMNAALDH1A1TRPM8
SCHEMBL148299 0.75 RXFP1 (0.48) MAPTKDM4ELMNAALDH1A1MAPK1
SCHEMBL3680399 0.75 MCL1 (0.50) MAPTKDM4ELMNAALDH1A1TRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7655641-B2 Sulfonamide derivatives as PPAR modulators ELI LILLY AND COMPANY (US) 2010-02-02 US disclosed
US-7655641-B2 Sulfonamide derivatives as PPAR modulators ELI LILLY AND COMPANY (US) 2010-02-02 US disclosed
US-7655641-B2 Sulfonamide derivatives as PPAR modulators ELI LILLY AND COMPANY (US) 2010-02-02 US disclosed
US-20060217433-A1 Sulfonamide derivatives as ppar modulators ELI LILLY AND COMPANY (US) 2006-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217433-A1 Sulfonamide derivatives as ppar modulators PPARD, PPARA, PPARG MAPT 3428/4885KDM4E 3238/4885LMNA 3056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.